Tatva Chintan Pharma Share Price Today
Tatva Chintan Pharma (TATVA) share price is trading at ₹1,605.80 on the NSE as of November 6, 2026 at 03:59 PM, down by 3.59% from its previous close of ₹1,665.60. In todays trading session TATVA reached a high of 1,663.00 and low of 1,585.00. The average traded price for today is 1,609.02. The 50 DMA stands at 1,721.54 and 200 DMA is at 1,410.47. Looking at intraday trend, the stock is in Downtrend.
Stock Overview
- Symbol : TATVA
- Open : ₹1,650.00
- Previous Close : ₹1,665.60
- Day's Range : ₹1,585.00 – ₹1,663.00
- 52-Week Range : ₹1,044.10 – ₹2,113.60
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
TATVA Stock Performance
Markets Today
High
1,663.00
Low
1,585.00
Open at
1,650.00
Prev Close
1,665.60
Volumes
55,357
Avg Price
1,609.02
Lower Circuit
1,284.70
Upper Circuit
1,926.90
Last Traded Details
Quantity
5
Time
15:59:45
Price Movement
Historical Performance
3 M High
2,113.60
3 M Low
1,520.00
1 Yr High
2,113.60
1 Yr Low
1,044.10
3 Yr High
2,113.60
3 Yr Low
621.00
5 Yr High
2,958.65
5 Yr Low
621.00
1-Year Performance
TATVA Pros and Cons
Revenue grows from ₹2,403.80 Cr in Q2 FY26 to ₹3,843.75 Cr in Q2 FY27 — sales recover after Q1 FY27 dip
EBITDA rises from ₹395.45 Cr in Q2 FY26 to ₹729.85 Cr in Q2 FY27 — operating profit recovers after Q1 FY27 dip
EBITDA margin improves from 16% in Q2 FY26 to 19% in Q2 FY27 — operating efficiency holds
EPS rises from ₹7.08 in Q2 FY26 to ₹16.00 in Q2 FY27 — earnings per share recovers strongly
SDA revenue mix rebounds from 35% in Q1 FY27 to 45% in Q2 FY27 — core segment regains share
Finance costs rise from ₹9.20 Cr in Q2 FY26 to ₹47.90 Cr in Q2 FY27 — borrowing costs squeeze profits
Short-term borrowings rise from ₹830.13 Cr in Q2 FY26 to ₹1,655.30 Cr in Q2 FY27 — near-term debt load increases
Inventory rises from ₹1,460.37 Cr in Q2 FY26 to ₹2,489.10 Cr in Q2 FY27 — working capital builds
Trade receivables rise from ₹1,014.10 Cr in Q2 FY26 to ₹1,783.77 Cr in Q2 FY27 — cash collection slows
TATVA Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 2 analysts
Buy
100%
Hold
0%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
TATVA Share Price History
TATVA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
3,756
PE Ratio
62.00
PB Ratio
4.79
Dividend Yield
0.12%
ROE
5.38%
ROCE
7.57%
Book Value (₹)
348.26
Face Value (₹)
10.00
Analyse TATVA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% |
| Domestic Institutional Investors (DII) | 3.86% | 3.33% | 2.99% | 3.11% | 3.21% |
| Foreign Institutional Investors (FII) | 3.39% | 4.17% | 3.82% | 3.93% | 4.38% |
| Public Investors | 18.29% | 17.91% | 18.32% | 17.48% | 17.08% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Tatva Chintan Pharma Return Calculator
Note: Past profits do not guarantee future returns.
TATVA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
TATVA Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for TATVA
Margin on TATVA
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
TATVA Financials Summary
In Crores
TATVA Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check TATVA latest Company Filings, Investor Presentation & Conference Call details.
TATVA Revenue Growth
All values are in Crores
Revenue
Profit
Loss
TATVA Similar Stocks
FAQs on TATVA
What is the share price of Tatva Chintan Pharma?
What is the 52W high and 52W low of Tatva Chintan Pharma?
What is the return on Tatva Chintan Pharma share?
- Past 1 year: 5.06%
- Past 3 years: 12.85%
- Past 5 years: -41.42%
What is the PE and PB Ratio of Tatva Chintan Pharma?
What is the EPS of Tatva Chintan Pharma?
What is the shareholding pattern of Tatva Chintan Pharma?
- DIIs - 3.21%
- FII - 4.38%
- Promoters - 72.02%
- Public Investors 17.08%
- Goverenment - 0.00%
How to buy Tatva Chintan Pharma shares online?
How to buy Tatva Chintan Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Tatva Chintan Pharma share
- Tap on “Buy”
